Global Laboratory Chemical Reagents Market to Reach US$18 Billion by 2017, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Laboratory Chemical Reagents market. The global market for Laboratory Chemical Reagents is projected to reach US$18 billion by the year 2017, driven by technological advancements that are enhancing scientific community’s ability to identify and produce important human therapeutic agents. Emerging applications areas and expanding commercial applications are expected to further fuel growth in the market.

Laboratory Chemical Reagents: A Global Strategic Business Report

Follow us on LinkedIn – Over the years, the laboratory chemical reagents market has witnessed robust growth led by constant refinements and advances in technologies such as cell culture, recombinant DNA, and bio-therapeutics that facilitated the production of several vital human therapeutic agents. Large-scale commercial applications and expanding applications in basic research are also fueling the demand for laboratory chemical reagents. Further, emerging disciplines such as neurosciences and proteomics offer potential growth opportunities for the Laboratory Chemical Reagents market. Biotechnology reagents and supplies represent one of the high growth markets. More specifically, market for DNA sequencing and protein synthesis reagents has increased dramatically in recent times. Since biotechnology is an industry based on diverse scientific and engineering processes, it has broad inter-industry applications and as such can be integrated into research and production operations of several industries.

As stated by the new market research report on Laboratory Chemical Reagents, the United States represents the largest regional market. Monoclonal & Polyclonal Antibodies are becoming increasingly significant, both as diagnostic and therapeutic tools for targeting diseased cells and cell compounds. A wide variety of new antibodies with the ability to offer effective treatment for several diseases are being introduced into the market, owing to technological advances in the field. The market for antibodies, especially for monoclonal antibodies that offer effective treatment for diseases including infectious and cardiovascular, inflammatory diseases and cancer and autoimmune diseases, is rapidly expanding. Physicians are increasingly turning towards monoclonal antibodies as a method of treatment for various diseases, since the effectiveness of traditional medicines has been found to be limited. The market for PCR reagents is growing on account of the increased awareness and acceptance of real-time PCR concept. Favorable funding initiatives of various governments are expected to foster the use of PCR technologies in laboratories, while universities are enhancing their curricula to familiarize students with PCR concepts.

Growth in cell culture manufacturing is mainly ascribed to improved production and development in the biopharmaceuticals industry. Reagents, sera and media used for biomanufacturing, process development and research, represent the major factors driving up growth in the cell culture-manufacturing sector. Innovations in the cell culture market would be driven by basic level biomedical research. Asian markets are key contributors the global sales of cell culture products. The region’s considerable share in the global revenues of sera, media and reagents is attributed to factors such as higher sales infrastructure investment by leading players in Japan and China, biomanufacturing demand, and increasing interest in stem cell research.

Major players profiled in the report include BD Biosciences, Beckman Coulter Inc., bioMérieux, EMD Chemicals Inc., GE Healthcare, Life Technologies Corporation, Meridian Life Science Inc., PerkinElmer Inc., SAFC Biosciences Inc., Shimadzu Biotech, Sigma-Aldrich Corp., Takara Bio Inc., Wako Pure Chemical Industries Ltd., Waters Corp., Lonza Biologics Ltd., QIAGEN, and Promega Corporation, among others.

The research report titled "Laboratory Chemical Reagents: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) across geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia Pacific, Latin America and Rest of World. Key product segments analyzed include Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression Vectors Cloning & Sequencing, Gene Synthesis, Extraction Kits, PCR Reagents, Enzymes, and Others), Biochemistry (IVD), Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing (Pesticide Residues and Others).

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website